Info
🌱來自: renal-cell-carcinoma
Non-clear cell histology-of-renal-cell-carcinoma
Clinical trial preferred Therapy extrapolated from clear cell; anti-VEGF agents w/ ↑ RR vs. mTOR inhibitors. Some response to chemo in selected cases
Siblings
- Epidemiology-of-renal-cell-carcinoma
- Histology and molecular biology-of-renal-cell-carcinoma
- Hereditary RCC and germline testing-of-renal-cell-carcinoma
- Clinical presentation-of-renal-cell-carcinoma
- Staging (TNM classification) and prognosis-of-renal-cell-carcinoma
- Treatment principles-of-renal-cell-carcinoma
- Systemic therapy for metastatic clear cell RCC
- Second-line therapies-of-renal-cell-carcinoma
- Combined-modality therapies-of-renal-cell-carcinoma
- Tyrosine kinase inhibitors-of-renal-cell-carcinoma
- Immunotherapies-of-renal-cell-carcinoma
- mTOR inhibitors-of-renal-cell-carcinoma
- Non-clear cell histology-of-renal-cell-carcinoma